Register Cart 0

Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back Subscribe

Editorial Review of 2012

Author(s): Sean L. Kitson

Volume 5, Issue 1, 2012

Page: [1 - 4] Pages: 4

DOI: 10.2174/1874471011205010001

Price: $65

Next »

Rights & Permissions Print Export Cite as

Article Metrics

9

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

For Visitors

Related Articles

Biological Activity In Vitro of Side-Chain Modified Analogues of Calcitriol
Current Pharmaceutical Design

An Integrative Informatics Approach to Explain the Mechanism of Action of N1-(Anthraquinon-2-yl) Amidrazones as BCR/ABL Inhibitors
Current Computer-Aided Drug Design

Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?
Current Medicinal Chemistry

MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy
Current Cancer Drug Targets

Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry

Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery

The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets

Mevalonate Kinase Deficiency: Disclosing the Role of Mevalonate Pathway Modulation in Inflammation
Current Pharmaceutical Design

Reversal of Resistance to Oxazaphosphorines
Current Cancer Drug Targets

The Role of P2X Receptors in Bone Biology
Current Medicinal Chemistry

Privileged Scaffolds Targeting Bromodomain-containing Protein 4
Current Topics in Medicinal Chemistry

The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies
Current Pharmaceutical Design

Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
Current Medicinal Chemistry

Differential Network Analysis in Human Cancer Research
Current Pharmaceutical Design

Chalcones in Cancer: Understanding their Role in Terms of QSAR
Current Medicinal Chemistry

Regulatory T Cells as Targets for Immunotherapy of Autoimmunity and Inflammation
Inflammation & Allergy - Drug Targets (Discontinued)

Lymphatics and Inflammation
Current Medicinal Chemistry

Ganoderma lucidum: A Potential for Biotechnological Production of Anti-Cancer and Immunomodulatory Drugs
Recent Patents on Anti-Cancer Drug Discovery

Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates
Central Nervous System Agents in Medicinal Chemistry

© 2023 Bentham Science Publishers | Privacy Policy